REPORT FROM ECTRIMS – BARCELONA, SPAIN – OCTOBER 7-10, 2015 – In 2007-2008, a retrospective analysis of over 9,000 patient records in Germany reported that about one-third of treated MS patients experienced one or more relapses in the preceding year and about 24% were candidates for treatment escalation according to clinical and radiological criteria (Maurer et al. Eur J Neurol 2011;18:1036-1045).
Since that time, the number of options for treatment optimization has expanded considerably, so a second study was performed in the period 2010-2014 (Schmidt et al. ECTRIMS 2015; abstract P294). Read More